Buy it for a resolution, not worth for day trading!is
Company spent total of 1 BLN $ so far to get this approved and market this product. Many companies don't get even FDA approval after spending this much, many Bio's we have seen.
Takeda spent close to $600 MLN. I bought 10 K and intend to buy another 40 K in the next few days once my funds are released not worried at all.
Can this go to zero? I doubt it, in stock market anything can happen.
Will it happen to Affy? I don't think so. They spent close to 600 MLN so far and still working on finding the root cause and resolve this issue. When the product worked for 24995 candidates out of 25000 people it is fixable issue.
The way in which they are putting out PR's, looks to me the current management want to help Takeda to grab this puppy. If there are institutions holding the stock, then it might deter the Management to grab cheap.
On top of it it is FDA, the ever waiting AMGN, this is a really complex puzzle.
I consider the odd of winning here is much higher!